✦ LIBER ✦

Extend use of adjuvant therapy in breast cancer?

Book ID: 120866988
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2001
Weight: 151 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200112770-00026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extended adjuvant endocrine therapy in h

Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer

✍ Strasser-Weippl, Kathrin; Badovinac-Crnjevic, Tanja; Fan, Lei; Goss, Paul E. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Extending the benefits of adjuvant thera

Extending the benefits of adjuvant therapy in early HR+ breast cancer

✍ Paul E. Goss 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 213 KB

Breast cancer adjuvant therapy use incre

Breast cancer adjuvant therapy use increases in the US

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Adjuvant therapy in breast cancer

✍ Legare, Robert D.; Strenger, Rochelle 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Breast cancer adjuvant therapy

✍ Paul P. Carbone 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 755 KB

Combined modality trials in early breast cancer have been underway since the 1960s and results are available to indicate varying degrees of success in Stage I and 11. The trials have involved more than 29,000 women in 61 randomized trials. The recommendations can be summarized by stage, estrogen rec

Adjuvant therapy of breast cancer

✍ Nancy E. Davidson; Martin D. Abeloff 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 605 KB

About 180,000 American women will be diagnosed with early stage breast cancer during 1993. In many of these patients breast cancer is a systemic disease at diagnosis and thus not curable by local treatment alone. The development of optimal forms of systemic adjuvant therapy has been a major area of